| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.1 |